Navigate

Wire Stories

Edgecore Networks Launches a Next-Generation 2.5G PoE Switch, the ECS501P, Targeting Enterprise Needs for a Full Gigabit Wi-Fi Upgrade

HSINCHU, Taiwan--(BUSINESS WIRE)--Edgecore Networks, a leading provider of traditional and open network solutions for enterprises,…

3 years ago

MITRE Australia Announces Collaborations with University Partners to Accelerate Innovation

New headquarters office in Canberra bridges government, industry, and academia to advance solutions to whole-of-nation…

3 years ago

Vaxxas Appoints Doug Cubbin as Chief Financial Officer

CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform,…

3 years ago

The Elephant Project Introduces “Baby Chaba” Stuffed Animal as the First of SaveUs™ Collection to be Named After Its Real-World Counterpart

Founder Kristina McKean Continues to Donate 100% of Net Proceeds from All Toy Purchases to…

3 years ago

Qurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study for the Treatment of Patients with Solid Tumors

SEOUL, South Korea--(BUSINESS WIRE)--#Qurient--Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea,…

3 years ago

The Elephant Project Introduces “Baby Chaba” Stuffed Animal as the First of SaveUs™ Collection to be Named After Its Real-World Counterpart

Founder Kristina McKean Continues to Donate 100% of Net Proceeds from All Toy Purchases to…

3 years ago

The Elephant Project Introduces “Baby Chaba” Stuffed Animal as the First of SaveUs™ Collection to be Named After Its Real-World Counterpart

Founder Kristina McKean Continues to Donate 100% of Net Proceeds from All Toy Purchases to…

3 years ago

Emerson Chosen as Automation Partner for World’s Largest Hydrogen Refueling Station for Commercial Vehicles

Collaboration with KOHYGEN will help decarbonize transportation industry while expanding global hydrogen refueling infrastructure SEOUL,…

3 years ago

Qurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study for the Treatment of Patients with Solid Tumors

SEOUL, South Korea--(BUSINESS WIRE)--#Qurient--Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea,…

3 years ago

Qurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study for the Treatment of Patients with Solid Tumors

SEOUL, South Korea--(BUSINESS WIRE)--#Qurient--Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea,…

3 years ago

Search